Dr. Krystle G. Wang, MD

Dr. Wang practices at Mountain View Endoscopy Center in Mountain View, California.

Dr. Wang's NPI, 1386960847, was assigned on April 8, 2010. Dr. Wang graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 2010. Dr. Wang holds California license A141215.

Dr. Wang's primary practice is Mountain View Endoscopy Center, at 2490 Hospital Dr Ste 211, Mountain View, CA 94040. The practice phone is (650) 988-7488.

Dr. Wang's primary practice is Mountain View Endoscopy Center in Mountain View, California. The medical group on file is Golden State Dermatology. Dmand AI also links Dr. Wang to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Wang's licenses on file in 2 states: California and Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, itchy rashes and psoriasis among the conditions Dr. Wang treats.

CMS data shows 2,007 Medicare services from Dr. Wang across 11 procedure codes in 2024, for 281 Medicare patients. Medicare paid $89,363 for them. Every service was in an office.

CMS counts 281 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 53, with 59% women.

In 2024, Dr. Wang wrote 462 Medicare Part D claims for 156 patients. 86% of them were for generic drugs. CMS names the drug for 376 of them, across 15 drugs with 11 or more claims each, at $194,054 in total drug cost. In 2023, CMS named 333 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth. CMS counts 563 procedures of removal of skin lesions by Dr. Wang, more than 88% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Wang in 2015. Dr. Wang's most frequent co-authors are Nazanin Saedi, MD and Katie Lynn Osley, MD.

Dmand AI links Dr. Wang to 1 clinical trial. Conditions studied include Dysplastic Nevus Syndrome and Nevus.

CMS Open Payments shows 903 general payments to Dr. Wang from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Allergan Inc. paid the most, $10,259.

Dr. Wang graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 2010.

Dr. Wang is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.